Read + Share
Amedeo Smart
Independent Medical Education
Kawamoto A, Hashida M, Ishida K, Furihata K, et al. Immunogenicity and safety of DS-5670d, an omicron XBB.1.5-targeting COVID-19 mRNA vaccine: A phase 3, randomized, active-controlled study. PLoS Med 2025;22:e1004499.PMID: 41082550
Email
LinkedIn
Privacy Policy